Be part of the knowledge.™

Neurology and Neurosurgery

830

LikeLikedUnlike

Episodes 61-75 of 94

MS Cognitive Insights: Management, Diagnostic, and Treatment Strategies
MinuteCE®
MS Cognitive Insights: Management, Diagnostic, and Treatment Strategies
- Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC
  Peer
- Ahmed Z. Obeidat, MD, PhD
  Peer
1.00 program credits
Brain Health in MS: A Comprehensive Approach
MinuteCE®
Brain Health in MS: A Comprehensive Approach
- Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC
  Peer
- Ahmed Z. Obeidat, MD, PhD
  Peer
1.00 program credits
PROs in MS: A New Era of Patient-Centric Care
MinuteCE®
PROs in MS: A New Era of Patient-Centric Care
- Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC
  Peer
- Ahmed Z. Obeidat, MD, PhD
  Peer
1.00 program credits
MinuteCE®
Improving Outcomes Earlier in Generalized Myasthenia Gravis:  Roadmap for Incorporating Targeted Therapies Into Clinical Practice 
- Nicholas J. Silvestri, MD
  Peer
- James F. Howard, Jr, MD
  Peer
1.00 credits 10 episodes
Beyond the Symptoms: The True Impact of gMG on Patients' Lives
MinuteCE®
Beyond the Symptoms: The True Impact of gMG on Patients' Lives
- Nicholas J. Silvestri, MD
  Peer
- James F. Howard, Jr, MD
  Peer
1.00 program credits
Understanding Disease Progression: The Shift From Ocular to Generalized MG
MinuteCE®
Understanding Disease Progression: The Shift From Ocular to Generalized MG
- Nicholas J. Silvestri, MD
  Peer
- James F. Howard, Jr, MD
  Peer
1.00 program credits
advertisement
Life-Threatening Events: Understanding and Preventing Myasthenic Crisis
MinuteCE®
Life-Threatening Events: Understanding and Preventing Myasthenic Crisis
- Nicholas J. Silvestri, MD
  Peer
- James F. Howard, Jr, MD
  Peer
1.00 program credits
Diagnosing gMG: Navigating Current Tools and Approaches
MinuteCE®
Diagnosing gMG: Navigating Current Tools and Approaches
- Nicholas J. Silvestri, MD
  Peer
- James F. Howard, Jr, MD
  Peer
1.00 program credits
Autoantibodies in MG: Their Role in Diagnosis and Treatment
MinuteCE®
Autoantibodies in MG: Their Role in Diagnosis and Treatment
- Nicholas J. Silvestri, MD
  Peer
- James F. Howard, Jr, MD
  Peer
1.00 program credits
Balancing Risk and Benefit: Traditional MG Treatments and Medications to Avoid
MinuteCE®
Balancing Risk and Benefit: Traditional MG Treatments and Medications to Avoid
- Nicholas J. Silvestri, MD
  Peer
- James F. Howard, Jr, MD
  Peer
1.00 program credits
The Science Behind FcRn Antagonists: A Deep Dive Into Their Mechanism of Action
MinuteCE®
The Science Behind FcRn Antagonists: A Deep Dive Into Their Mechanism of Action
- Nicholas J. Silvestri, MD
  Peer
- James F. Howard, Jr, MD
  Peer
1.00 program credits
FcRn Antagonists in Myasthenia Gravis: A New Era in Targeted Therapy
MinuteCE®
FcRn Antagonists in Myasthenia Gravis: A New Era in Targeted Therapy
- Nicholas J. Silvestri, MD
  Peer
- James F. Howard, Jr, MD
  Peer
1.00 program credits
advertisement
Optimizing FcRn Therapy: Addressing and Reducing Adverse Reactions
MinuteCE®
Optimizing FcRn Therapy: Addressing and Reducing Adverse Reactions
- Nicholas J. Silvestri, MD
  Peer
- James F. Howard, Jr, MD
  Peer
1.00 program credits
Precision Medicine in Myasthenia Gravis: Crafting Personalized Treatment Strategies
MinuteCE®
Precision Medicine in Myasthenia Gravis: Crafting Personalized Treatment Strategies
- Nicholas J. Silvestri, MD
  Peer
- James F. Howard, Jr, MD
  Peer
1.00 program credits
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
CME/CE
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
- James R. Bateman, MD, MPH
  Peer
- Jerome A. Barakos, MD
  Peer
- Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
  Peer
- B. Joy Snider, MD, PhD
  Peer
0.50 credits

Program Chapters

Segment Chapters

Playlist:

Recommended